Artelo Biosciences Novel, endocannabinoid system modulating therapeutics
Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Our programs have the potential to dramatically improve patient care in major markets.
We expect to deliver on the promise of new medicines to treat a wide range of diseases and conditions for patients in need of better outcomes. By doing so, we will create value for patients, physicians, and our investors.
Showcase to 300+ investors and pharma at our 5th flagship LSX World Congress.
Plus save £500 before 14th December!
LSX is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.